Human Insulin Market 2026 Size, Global Industry Analysis by Growth and Top Key Players | Boston Scientific Corporation, Sanofi and More

The global "human insulin market" size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around 425 million people across the world suffer from diabetes. This shows that the rising prevalence of diabetes is propelling growth in the market. Fortune Business Insights in a new report, titled "Human Insulin Market Size, Share & Industry Analysis, By Type (Analogue Insulin (Long-Acting, Fast Acting, Premix), Traditional Human Insulin (Long-Acting, Short-Acting, Fast Acting, Premix)), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Regional Forecast, 2019-2026" predicts the market to exhibit a CAGR of 3.4% during the forecast period. In 2018, the market value stood at USD 21.26 billion in 2018. The adoption of delivery devices primarily for insulin administration is increasing, thus driving the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-insulin-market-100395

The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Key Features of Human Insulin Market Report:
o Overview, Industry Life Cycle Analysis, Supply Chain Analysis
o Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
o Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
o Market attractiveness and Associated Growth Opportunities
o Strategic Growth Opportunities for the Existing and New Players
o Key Success Factors

Eli Lilly & Company to Launch Analogue Humalog Insulin in the U.S.

Among products, analogue insulin covered the maximum part in the human insulin market share in 2018. Analogue insulin helps to control blood sugar levels in people suffering from type 1 and type 2 diabetes. Driven by this, the adoption of analogue insulin is increasing, which increases the human insulin market size. This, coupled with the recent launch of generic insulin, is expected to contribute to the growth of the market. For instance, Eli Lilly and Company announced the launch of a generic version of analogue Humalog insulin called Insulin Lispro in April 2019. Owing to the cheaper rates of Humalog, this insulin is more accessible to diabetic patients in the country. This segment is expected to drive the human insulin market in the foreseeable future.

Key Companies and Manufacturers Covered:

o Novo Nordisk A/S
o Eli Lilly and Company
o Boston Scientific Corporation
o Sanofi
o Boehringer Ingelheim International GmbH
o Biocon
o Tonghua Dongbao Pharmaceutical
o Julphar
o Wockhard
o Other prominent players

Novo Nordisk to Expand its Insulin Manufacturing Plant in India

The prevalence of diabetes is increasing across the world, one of the primary human insulin market trends. In a 2017 report published by the Centers for Diseases Control and Prevention (CDC), it was found that around 30.3 million people in the U.S. suffered from diabetes. Furthermore, it was stated that among the above numbers, around 23.1 million were diagnosed, while the rest were not diagnosed. The increasing adoption of a sedentary lifestyle is the primary reason behind the prevalence of diabetes. This, as a result, will fuel demand for insulin pens and insulin injections among masses. Consequently, Biocon plans to develop an oral insulin tablet called Tregopil for people suffering from Type 1 and Type 2 diabetes. This tablet aims to improve the post-prandial blood sugar control and has minimum side-effects. As per the report, companies such as Eli Lilly and Company, Sanofi, and Novo Nordisk A/S hold the maximum share in the global market.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/human-insulin-market-100395

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Key Insights
o Prevalence of Diabetes - Key Countries
o Pipeline Analysis
o Brand Analysis
o Key Market Strategies of Leading Players
o Overview of Regulatory Scenario - Key Countries
o Global Human Insulin Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Type
? Analogue Insulin
o Long-acting
o Fast-acting
o Premix
? Traditional Human Insulin
o Long-acting
o Short-acting
o Fast-acting
o Premix
o Market Analysis, Insights and Forecast - By Diabetes Type
? Diabetes Type 1
? Diabetes Type 2
o Market Analysis, Insights and Forecast - By Distribution Channel
? Retail Pharmacies
? Hospital Pharmacies
? Online Pharmacies
o Market Analysis, Insights and Forecast - By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa
Continue....
Human Insulin Market Segmentation:
By Type
o Analogue Insulin
o Long-acting
o Fast-acting
o Premix
o Traditional Human Insulin
o Long-acting
o Short-acting
o Fast-acting
o Premix
By Diabetes Type
o Diabetes Type 1
o Diabetes Type 2
By Distribution Channel
o Retail Pharmacies
o Hospital Pharmacies
o Online Pharmacies
By Geography
o North America (U.S. and Canada)
o Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
o Latin America (Brazil, Mexico, and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Reasons to Purchase this Report:

o Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
o Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market's expansion.
o Market dynamics and opportunities for growth for players in the near future.
o Competitive landscape describing the market revenue shares of key players.
o Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.

Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.

Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/100395

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.